Sunday, November 3, 2024
HomeTagsPhase 3

Phase 3

Eiger BioPharmaceuticals Announces Second Positive Interim Analysis and Continuation of Dosing of Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 Patients

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure Hepatitis Delta Virus (HDV) and other...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics